{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:53:51Z","timestamp":1785556431820,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003151","name":"Fonds de recherche du Qu\u00e9bec \u2013 Nature et technologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Math Biol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s11538-025-01532-z","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T21:02:27Z","timestamp":1760734947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Generation of Virtual Populations for Quantitative Systems Pharmacology Through Advanced Sampling Methods"],"prefix":"10.1007","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5756-9340","authenticated-orcid":false,"given":"Miriam","family":"Schirru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Brier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Zugaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahima","family":"Nekka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"1532_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/psp4.12063","volume":"5","author":"R Allen","year":"2016","unstructured":"Allen R, Rieger T, Musante C (2016) Efficient generation and selection of virtual populations in quantitative systems pharmacology models. CPT Pharmacomet Syst Pharmacol 5:140\u2013146. https:\/\/doi.org\/10.1002\/psp4.12063","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"1532_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.13270","author":"N Braniff","year":"2024","unstructured":"Braniff N, Joshi T, Cassidy T et al (2024) An integrated quantitative systems pharmacology virtual population approach for calibration with oncology efficacy endpoints. CPT Pharmacomet Syst Pharmacol. https:\/\/doi.org\/10.1002\/psp4.13270","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"1532_CR3","doi-asserted-by":"publisher","unstructured":"Buis S, Lecharpentier P, Vezy R, Giner M (2023) CroptimizR: a package to estimate parameters of crop models. https:\/\/doi.org\/10.5281\/zenodo.4066451","DOI":"10.5281\/zenodo.4066451"},{"key":"1532_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.12793\/tcp.2020.28.e12","volume":"28","author":"D Chae","year":"2020","unstructured":"Chae D (2020) Introduction to dynamical systems analysis in quantitative systems pharmacology: basic concepts and applications. Transl Clin Pharmacol 28:109\u2013125. https:\/\/doi.org\/10.12793\/tcp.2020.28.e12","journal-title":"Transl Clin Pharmacol"},{"key":"1532_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-1-0716-2265-0_8","volume-title":"Systems Medicine","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Straube R, Alnaif AE et al (2022) Virtual Populations for Quantitative Systems Pharmacology Models. In: Bai JPF, Hur J (eds) Systems Medicine. Springer, New York, pp 129\u2013179"},{"key":"1532_CR6","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00228-024-03763-w","volume":"80","author":"M Chougule","year":"2024","unstructured":"Chougule M, Kollipara S, Mondal S, Ahmed T (2024) A critical review on approaches to generate and validate virtual population for physiologically based pharmacokinetic models: methodologies, case studies and way forward. Eur J Clin Pharmacol 80:1903\u20131922. https:\/\/doi.org\/10.1007\/s00228-024-03763-w","journal-title":"Eur J Clin Pharmacol"},{"key":"1532_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1212981","author":"P Coto-Segura","year":"2023","unstructured":"Coto-Segura P, Seg\u00fa-Verg\u00e9s C, Martorell A et al (2023) A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1212981","journal-title":"Front Immunol"},{"key":"1532_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11538-024-01345-6","volume":"86","author":"JL Gevertz","year":"2024","unstructured":"Gevertz JL, Wares JR (2024) Assessing the role of patient generation techniques in virtual clinical trial outcomes. Bull Math Biol 86:119. https:\/\/doi.org\/10.1007\/s11538-024-01345-6","journal-title":"Bull Math Biol"},{"key":"1532_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/psp4.13288","volume":"14","author":"H Iwata","year":"2025","unstructured":"Iwata H, Saito R (2025) Accelerating virtual patient generation with a Bayesian optimization and machine learning surrogate model. CPT Pharmacomet Syst Pharmacol 14:486\u2013494. https:\/\/doi.org\/10.1002\/psp4.13288","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"1532_CR10","doi-asserted-by":"publisher","DOI":"10.1029\/2011WR010608","volume":"48","author":"E Laloy","year":"2012","unstructured":"Laloy E, Vrugt JA (2012) High-dimensional posterior exploration of hydrologic models using multiple-try DREAM(ZS) and high-performance computing. Water Resour Res 48:2011WR010608. https:\/\/doi.org\/10.1029\/2011WR010608","journal-title":"Water Resour Res"},{"key":"1532_CR11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/psp4.12999","volume":"12","author":"RC Myers","year":"2023","unstructured":"Myers RC, Augustin F, Huard J, Friedrich CM (2023) Using machine learning surrogate modeling for faster QSP VP cohort generation. CPT Pharmacomet Syst Pharmacol 12:1047\u20131059. https:\/\/doi.org\/10.1002\/psp4.12999","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"1532_CR12","unstructured":"(2019) Products - Data Briefs - Number 132 - October 2013. Accessed 20 Mar 2025; https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db132.htm."},{"key":"1532_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pbiomolbio.2018.06.002","volume":"139","author":"TR Rieger","year":"2018","unstructured":"Rieger TR, Allen RJ, Bystricky L et al (2018) Improving the generation and selection of virtual populations in quantitative systems pharmacology models. Prog Biophys Mol Biol 139:15\u201322. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2018.06.002","journal-title":"Prog Biophys Mol Biol"},{"key":"1532_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.910789","volume":"13","author":"TR Rieger","year":"2022","unstructured":"Rieger TR, Allen RJ, Musante CJ (2022) A quantitative systems pharmacology model of liver lipid metabolism for investigation of non-alcoholic fatty liver disease. Front Pharmacol 13:910789. https:\/\/doi.org\/10.3389\/fphar.2022.910789","journal-title":"Front Pharmacol"},{"key":"1532_CR15","doi-asserted-by":"publisher","unstructured":"Rieger T (2018) openPfizer\/vpop-gen: Release 2.0 for publication. https:\/\/doi.org\/10.5281\/zenodo.999551","DOI":"10.5281\/zenodo.999551"},{"key":"1532_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-024-09903-0","author":"M Schirru","year":"2024","unstructured":"Schirru M, Charef H, Ismaili K-E et al (2024) Predicting efficacy assessment of combined treatment of radiotherapy and nivolumab for NSCLC patients through virtual clinical trials using QSP modeling. J Pharmacokinet Pharmacodyn. https:\/\/doi.org\/10.1007\/s10928-024-09903-0","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1532_CR17","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1093\/bioinformatics\/btaa1026","volume":"36","author":"S Sinisi","year":"2020","unstructured":"Sinisi S, Alimguzhin V, Mancini T et al (2020) Complete populations of virtual patients for in silico clinical trials. Bioinformatics 36:5465\u20135472. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1026","journal-title":"Bioinformatics"},{"key":"1532_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/psp4.12546","volume":"9","author":"RJ Sov\u00e9","year":"2020","unstructured":"Sov\u00e9 RJ, Jafarnejad M, Zhao C et al (2020) QSP-IO: a quantitative systems pharmacology toolbox for mechanistic multiscale modeling for immuno-oncology applications. CPT Pharmacomet Syst Pharmacol 9:484\u2013497. https:\/\/doi.org\/10.1002\/psp4.12546","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"1532_CR19","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1194\/jlr.M031930","volume":"53","author":"NCA Van De Pas","year":"2012","unstructured":"Van De Pas NCA, Woutersen RA, Van Ommen B et al (2012) A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans. J Lipid Res 53:2734\u20132746. https:\/\/doi.org\/10.1194\/jlr.M031930","journal-title":"J Lipid Res"},{"key":"1532_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.envsoft.2015.08.013","volume":"75","author":"JA Vrugt","year":"2016","unstructured":"Vrugt JA (2016) Markov chain Monte Carlo simulation using the DREAM software package: theory, concepts, and MATLAB implementation. Environ Model Softw 75:273\u2013316. https:\/\/doi.org\/10.1016\/j.envsoft.2015.08.013","journal-title":"Environ Model Softw"},{"key":"1532_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1515\/IJNSNS.2009.10.3.273","volume":"10","author":"JA Vrugt","year":"2009","unstructured":"Vrugt JA, ter Braak CJF, Diks CGH et al (2009) Accelerating markov chain monte carlo simulation by differential evolution with self-adaptive randomized subspace sampling. Int J Nonlinear Sci Numer Simul 10:273\u2013290. https:\/\/doi.org\/10.1515\/IJNSNS.2009.10.3.273","journal-title":"Int J Nonlinear Sci Numer Simul"},{"key":"1532_CR22","unstructured":"Vrugt JA (2025) jaspervrugt\/DREAM-Suite. https:\/\/github.com\/jaspervrugt\/DREAM-Suite"},{"key":"1532_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002100","volume":"9","author":"H Wang","year":"2021","unstructured":"Wang H, Ma H, Sov\u00e9 RJ et al (2021) Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer. J Immunother Cancer 9:e002100. https:\/\/doi.org\/10.1136\/jitc-2020-002100","journal-title":"J Immunother Cancer"},{"key":"1532_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00405-9","volume":"7","author":"H Wang","year":"2023","unstructured":"Wang H, Arulraj T, Kimko H, Popel AS (2023) Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition. NPJ Precis Oncol 7:55. https:\/\/doi.org\/10.1038\/s41698-023-00405-9","journal-title":"NPJ Precis Oncol"},{"key":"1532_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10928-021-09798-1","volume":"49","author":"T Zhang","year":"2022","unstructured":"Zhang T, Tyson JJ (2022) Understanding virtual patients efficiently and rigorously by combining machine learning with dynamical modelling. J Pharmacokinet Pharmacodyn 49:117\u2013131. https:\/\/doi.org\/10.1007\/s10928-021-09798-1","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1532_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.hlc.2016.04.025","volume":"25","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wu N-Q, Li S et al (2016) Non-HDL-C is a better predictor for the severity of coronary atherosclerosis compared with LDL-C. Heart Lung Circ 25:975\u2013981. https:\/\/doi.org\/10.1016\/j.hlc.2016.04.025","journal-title":"Heart Lung Circ"},{"key":"1532_CR27","doi-asserted-by":"publisher","DOI":"10.1063\/5.0170329","volume":"34","author":"D Zugaj","year":"2024","unstructured":"Zugaj D, Fenneteau F, Tremblay P-O, Nekka F (2024) Dynamical behavior-based approach for the evaluation of treatment efficacy: the case of immuno-oncology. Chaos Woodbury N 34:013142. https:\/\/doi.org\/10.1063\/5.0170329","journal-title":"Chaos Woodbury N"},{"key":"1532_CR28","unstructured":"Zugaj D, Nekka F (2025) Identification and characterization of virtual sub-populations through phenotype-guided filtering. The challenging case of nonidentifiable models in the context of therapeutic evaluation."}],"container-title":["Bulletin of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-025-01532-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11538-025-01532-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-025-01532-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:22:19Z","timestamp":1762345339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11538-025-01532-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1532"],"URL":"https:\/\/doi.org\/10.1007\/s11538-025-01532-z","relation":{},"ISSN":["0092-8240","1522-9602"],"issn-type":[{"value":"0092-8240","type":"print"},{"value":"1522-9602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"165"}}